The ATR-Chk1 pathway plays a role in the generation of centrosome aberrations induced by Rad51C dysfunction

Nucleic Acids Research

Volumn 37, Issue 12, 2009, Pages 3959-3968

  Katsura, Mari ^a,b   Tsuruga, Takanori ^b   Date, Osamu ^b   Yoshihara, Takashi ^b   Ishida, Mari ^b   Tomoda, Yoshitaka ^a   Okajima, Miyuki ^a   Takaku, Motoki ^c   Kurumizaka, Hitoshi ^c   Kinomura, Aiko ^b   Mishima, Hiromu K ^b   Miyagawa, Kiyoshi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c WASEDA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CAFFEINE; CHECKPOINT KINASE 1; HISTONE GAMMA H2AX; HISTONE H2AX; PROTEIN SERINE THREONINE KINASE INHIBITOR; RAD51 PROTEIN; RAD51C PROTEIN; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; CELL MUTANT; CELL STRAIN HCT116; CELL STRAIN HT1080; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CENTROSOME; CENTROSOME ABERRATION; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; INTERPHASE; KNOCKOUT GENE; METAPHASE; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR CELL LINE;

ANEUPLOIDY; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CENTROSOME; DNA-BINDING PROTEINS; HUMANS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECOMBINATION, GENETIC; RNA INTERFERENCE;

CRICETINAE; VERTEBRATA;

EID: 67651163668     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp262     Document Type: Article

References (34)

1. West,S.C. (2003) Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol., 4, 435-445.
2. Thacker,J. (2005) The RAD51 gene family, genetic instability and cancer. Cancer Lett., 219, 125-135.
3. Masson,J.-Y., Tarsounas,M.C., Stasiak,A.Z., Stasiak,A., Shah,R., McIlwraith,M.J., Benson,F.E. and West,S.C. (2001) Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev., 15, 3296-3307.
4. Liu,N., Schild,D., Thelen,M.P. and Thompson,L.H. (2002) Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells. Nucleic Acids Res., 30, 1009-1015.
5. Bettencourt-Dias,M. and Glover,D.M. (2007) Centrosome biogenesis and function: Centrosomics brings new understanding. Nat. Rev. Mol. Cell Biol., 8, 451-463.
6. Nigg,E.A. (2006) Origins and consequences of centrosome aberrations in human cancers. Int. J. Cancer, 119, 2717-2723.
7. Doxsey,S., Zimmerman,W. and Mikule,K. (2005) Centrosome control of the cell cycle. Trends Cell Biol., 15, 303-311.
8. Griffin,C.S., Simpson,P.J., Wilson,C.R. and Thacker,J. (2000) Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat. Cell Biol., 2, 757-761.
9. Smiraldo,P.G., Gruver,A.M., Osborn,J.C. and Pittman,D.L. (2005) Extensive chromosomal instability in Rad51d-de.cient mouse cells. Cancer Res., 65, 2089-2096.
10. Date,O., Katsura,M., Ishida,M., Yoshihara,T., Kinomura,A., Sueda,T. and Miyagawa,K. (2006) Haploinsufficiency of RAD51B causes centrosome fragmentation and aneuploidy in human cells. Cancer Res., 66 6018-6024.
11. Godthelp,B.C., Wiegant,W.W., van Duijn-Goedhart,A., Scharer,O.D., van Buul,P.P.W., Kanaar,R. and Zdzienicka,M.Z. (2002) Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Nucleic Acids Res., 30, 2172-2182.
12. L0indh,A.R., Schultz,N., Saleh-Gohari,N. and Helleday,T. (2007) RAD51C (RAD51L2) is involved in maintaining centrosome number in mitosis. Cytogenet. Genome Res., 116, 38-45.
13. Dodson,H., Bourke,E., Jeffers,L.J., Vagnarelli,P., Sonoda,E., Takeda,S., Earnshaw,W.C., Merdes,A. and Morrison,C. (2004) Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. EMBO J., 23, 3864-3873.
14. Daboussi,F., Thacker,J. and Lopez,B.S. (2005) Genetic interactions between RAD51 and its paralogues for centrosome fragmentation and ploidy control, independently of the sensitivity to genotoxic stresses. Oncogene, 24, 3691-3696.
15. Pujana,M.A., Han,J.D., Starita,L.M., Stevens,K.N., Tewari,M., Ahn,J.S., Rennert,G., Moreno,V., Kirchho.,T., Gold,B et al. (2007) Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat. Genet., 39, 1338-1349.
16. Bourke,E., Dodson,H., Merdes,A., Cu.e,L., Zachos,G., Walker,M., Gillespie,D. and Morrison,C.G. (2007) DNA damage induces Chk1-dependent centrosome amplification. EMBO Rep., 8, 603-609.
17. Miyagawa,K., Tsuruga,T., Kinomura,A., Usui,K., Katsura,M., Tashiro,S., Mishima,H. and Tanaka,K. (2002) A role for RAD54B in homologous recombination in human cells. EMBO J., 21, 175-180.
18. Yoshihara,T., Ishida,M., Kinomura,A., Katsura,M., Tsuruga,T., Tashiro,S., Asahara,T. and Miaygawa,K. (2004) XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cells. EMBO J., 23, 670-680.
19. Yokoyama,H., Kurumizaka,H., Ikawa,S., Yokoyama,S. and Shibata,T. (2003) Holliday junction binding activity of the human Rad51B protein. J. Biol. Chem., 278, 2767-2772.
20. 2/M checkpoints and promote rereplication in human cells. Nucleic Acids Res., 34 880-892.
21. Bärlund,M., Monni,O., Kononen,J., Cornelison,R., Torhorst,J., Sauter,G., Kallioniemi,O-P. and Kallioniemi,A. (2000) Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res., 60, 5340-5344.
22. Wu,G.-J., Sinclair,C.S., Paape,J., Ingle,J.N., Roche,P.C., James,C.D. and Couch,F.J. (2000) 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGMA1B genes. Cancer Res., 60, 5371-5375.
23. Takata,M., Sasaki,M.S., Tachiiri,S., Fukushima,T., Sonoda,E., Schild,D., Thompson,L.H. and Takeda,S. (2001) Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol. Cell Biol., 21, 2858-2866.
24. Lio,Y.-C., Schild,D., Brenneman,M.A., Redpath,J.L. and Chen,D.J. (2004) Human Rad51C deficiency destabilizes XRCC3, impairs recombination, and radiosensitizes S/G2-phase cells. J. Biol. Chem., 279, 42313-42320.
25. 2-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1. Cancer Res., 62 5743-5748.
26. Löffler,H., Bochtler,T., Fritz,B., Tews,B., Ho,A.D., Lukas,J., Bartek,J. and Krämer,A. (2007) DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint function. Cell Cycle 6, 2541-2548.
27. Brown,K.D., Rathi,A., Kamath,R., Beardsley,D.I., Zhan,Q., Mannino,J.L. and Baskaran,R. (2003) The mismatch repair system is required for S-phase checkpoint activation. Nat. Genet., 33, 80-84.
28. Zhang,S., Hemmerich,P. and Grosse,F. (2007) Centrosomal localization of DNA damage checkpoint proteins. J. Cell Biochem., 101, 451-465.
29. Griffith,E., Walker,S., Martin,C.-A., Vagnarelli,P., Stiff,T., Vernay,B., Sanna,N.A., Saggar,A., Hamel,B., Earnshaw,W.C. et al. (2008) Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat. Genet., 40, 232-236.
30. Rauch,A., Thiel,C.T., Schindler,D., Wick,U., Crow,Y.J., Ekici,A.B., van Essen,A.J., Goecke,T.O., Al-Gazali,L., Chrzanowska,K.H. et al. (2008) Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science, 319, 816-819.
31. O'Driscoll,M., Ruiz-Perez,V.L., Woods,C.G., Jeggo,P.A. and Goodship,J.A. (2003) A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet., 33, 497-501.
32. Jazayeri,A., Falck,J., Lukas,C., Bartek,J., Smith,G.C.M., Lukas,J. and Jackson,S.P. (2006) ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol., 8, 37-45.
33. Sti.,T., Walker,S.A., Cerosaletti,K., Goodarzi,A.A., Petermann,E., Concannon,P., O'Driscoll,M. and Jeggo,P.A. (2006) ATRdependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J., 25, 5775-5782.
34. Liu,Y., Masson,J.-Y., Shah,R., O'Regan,P. and West,S.C. (2004) RAD51C is required for Holliday junction processing in mammalian cells. Science 303, 243-246.